Gene Expression Analysis Market by Technology, Services, Consumables & Applications will reach $4.3 Billion by 2018

Gene expression analysis has emerged as a major advancement in the fields of drug discovery, diagnostics, and biomedical research. Since the completion of the Human Genome Project in 2003, numerous methods are being developed to improve the efficiency and effectiveness of gene expression profiling and sequencing. it is an important process, as it enables researchers to decipher the functions of genes. By sequencing genes, researchers can determine how diseases affect a cell. Genome-wide analysis can be used to accurately classify diseases. This has led to its increased use in various applications such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers.

The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market.

Get PDF Brochure:

The global market is segmented into instrumentation, consumables, and services. Based on technologies, the gene expression analysis instrumentation market is further segmented into DNA microarrays, real-time PCR, next-generation sequencing, and others. The consumables market is further categorized into DNA chips and reagents, while the services market is sub-segmented into gene expression profiling services, bioinformatics solutions, data analysis software, and others.

Based on applications, the global market is broadly categorized into diagnostics, drug discovery, biomarkers, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW).

Speak to Analyst:

North America dominated the global market, followed by Europe and Asia. The continued developments in the North American market are triggered by the increase in funding, to address the growth in the number of cancer patients. Asia is expected to grow at the highest CAGR. This can be attributed to the presence of high-growth markets such as India and China, improved funding scenario in this region, increasing number of conferences and exhibitions on gene expression, and increased focus on cancer research.

Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global market.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @